Summary
The product IL-BU200, submitted by Iron Lion Pharma, underwent independent testing to verify its authenticity and potency. The sample’s manufacturer and batch number were unknown. It was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the concentration of Boldenone Undecylenate at 246.59 mg/ml.
The testing process began on 21 February 2024, with the sample received on 7 March 2024, and analysis completed on 8 March 2024. While the results confirm the presence of the expected compound, the measured concentration is slightly above the labeled claim, highlighting the importance of independent verification to ensure product consistency. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Iron Lion Pharma
- Product Name: IL-BU200
- Active Ingredient: Boldenone Undecylenate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #39500
- Testing Ordered: 21 February 2024
- Sample Received: 7 March 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Iron Lion Pharma
- Analysis Paid For By: Iron Lion Pharma
Testing Results
- Measured Concentration: 246.59 mg/ml (slightly above the expected 200 mg/ml)
Verification Details
Verification URL: https://janoshik.com/tests/39500_SK2ZCKT76RQI
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Boldenone Undecylenate is present at 246.59 mg/ml, exceeding the expected 200 mg/ml specification. While this deviation is not extreme, maintaining precise concentrations is crucial for consistency and consumer confidence. However, due to the lack of manufacturer and batch details, assessing consistency across different samples remains challenging. This highlights the need for further verification from independent sources to ensure product reliability and safety. Janoshik Analytical is recognized for its rigorous testing protocols, but consumers should remain cautious when purchasing products with limited traceability.
Conclusion
The analysis confirms that IL-BU200 contains 246.59 mg/ml of Boldenone Undecylenate, slightly above the labeled concentration. However, due to the lack of manufacturer and batch details, it is recommended that consumers exercise caution when considering this product. Ongoing testing and third-party validation are crucial for verifying quality and consistency. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer and batch details were not provided, which may affect product traceability. Readers are encouraged to use this information responsibly and consider third-party validation before use.
